Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications

Journal of Managed Care Pharmacy

Volumn 20, Issue 9, 2014, Pages 905-911

  Porter, Angela K ^a   Taylor, Shawn Riser ^a,b   Yabut, Abigail H ^c   Al Achi, Antoine ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WINGATE UNIVERSITY   (United States)

^c HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

^d CAMPBELL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN INHIBITOR; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMORBIDITY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL DOCUMENTATION; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PILL BOX CLINIC; PROSPECTIVE STUDY; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNCONTROLLED HYPERTENSION; VETERAN; CHI SQUARE TEST; CLINICAL ARTICLE; COMBINATION DRUG THERAPY; LOGISTIC REGRESSION ANALYSIS; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; DEVICES; DRUG COMBINATION; DRUG EFFECTS; HEALTH IMPACT ASSESSMENT; MIDDLE AGED; OUTPATIENT DEPARTMENT; PUBLIC HOSPITAL; STATISTICAL MODEL; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEALTH IMPACT ASSESSMENT; HOSPITALS, RURAL; HOSPITALS, VETERANS; HUMANS; HYPERTENSION; LOGISTIC MODELS; LOST TO FOLLOW-UP; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORTH CAROLINA; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES;

EID: 84906082705     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.9.905     Document Type: Article

References (26)

1. U.S. National Institutes of Health. National Heart, Lung, and Blood Institute. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. August 2004. Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed June 18, 2014.
2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-13. Available at: http://hyper.ahajournals.org/content/25/3/305.long#cited-by. Accessed June 18, 2014.
3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206. Available at: http://jama.jamanetwork.com/article. aspx?articleid=196894. Accessed June 18, 2014.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
5. Mapes RE. Physicians' drug innovation and relinquishment. Soc Sci Med. 1977;11(11-13):619-24.
6. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1(7918):1205-07.
7. Rudd P. Compliance with antihypertensive therapy: raising the bar of expectations. Am J Manag Care. 1998;4(7):957-66. Available at: http://www. ajmc.com/pdf-access/11099/1. Accessed June 18, 2014.
8. Schneider M, Fallab-Stubi C, Waeber B. The place of microelectronic system in measuring compliance. In: Metry J, Meyer U, eds. Drug Regimen Compliance: Issues in Clinical Trials and Patient Management. Chichester, UK: John Wiley and Sons; 1999:85-86.
9. Nessman DG, Carnahan JE, Nugent CA. Increasing compliance: patientoperated hypertension groups. Arch Intern Med. 1980;140(11):1427-30.
10. Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess. 1998;2(11):iiv, 1-78. Available at: http://www.journalslibrary.nihr.ac.uk/__data/assets/ pdf_file/0009/64782/FullReport-hta2110.pdf. Accessed June 18, 2014
11. Lüscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertens Suppl. 1985;3(1):S3-S9.
12. Kotchen TA. Hypertensive vascular disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012:2042-59.
13. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13.
14. Neal B, MacMahon S, Chapman N; the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet. 2000;356(9246):1955-64.
15. Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm. 1980;37(3):379-85.
16. Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908-15. Available at: http://cid.oxfordjournals. org/content/45/7/908.full.pdf+html. Accessed June 18, 2014.
17. Nochowitz B, Shapiro NL, Nutescu EA, Cavallari LH. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Ann Pharmacother. 2009;43(7):1165-72.
18. Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001;19(2):335-41.
19. Burnier M. Compliance in hypertension. EDTNA ERCA J. 2005;31(3):152-55.
20. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens (Greenwich). 2000;2(4):258-62.
21. Bryson CL, Au DH, Young B, McDonnell MG, Fihn SD. A refill adherence algorithm for multiople short intervals to estimate refill compliance (ReComp). Med Case. 2007;45(6):497-504.
22. Whelton PK, He J, Appel LJ. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882-88.
23. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to JNC VI risk stratification. Hypertension. 2000;35(2):539-43. Available at: http://hyper. ahajournals.org/content/35/2/539.full.pdf+html. Accessed June 18, 2014.
24. Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract. 2010;64(2):169-81.
25. Esposti LD, Saragoni S, Batacchi P, Geppetti P, Buda S, Esposti ED. Antihypertensive therapy among newly treated patients: an analysis of adherence and cost of treatment over years. Clinicoecon Outcomes Res. 2010;2:113-20. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3169964/. Accessed June 18, 2014.
26. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(Suppl 1):S11-S66. Available at: http://care. diabetesjournals.org/content/36/Supplement_1/S11.full.pdf+html. Accessed June 18, 2014.